HCA Healthcare stock trades above $410 as recent earnings and institutional demand shape outlook
Published on 08/19/2026 at 12:05 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
HCA Healthcare stock (ISIN US40412C1018) is trading in the low $410s in August 2026, supported by recent quarterly earnings growth and ongoing institutional demand as investors weigh the companys role in US hospital and healthcare services on August 19, 2026. Recent data indicate that the shares have been changing hands slightly above $410 in recent sessions, while current analyst estimates still point to further earnings expansion for the full year 2026.
Shares hover above $410 after recent close
Market data indicate that HCA Healthcare stock closed at $404.98 on August 17, 2026, during regular US trading hours, with an extended trading indication around $412 on August 18, 2026. One recent quote source shows HCA Healthcare stock at $412.28 at the close on August 18, 2026, representing a gain of 1.80 percent for that session compared with the previous close. Another live-quote overview lists the share price at $411.77 as of August 19, 2026 at 1:29 a.m. IST, highlighting that the stock opened that session at $409.36 after a prior close at $405.10.
The current trading range also shows that HCA Healthcare stock has moved between a 12 month low of $353.99 and a 12 month high of $556.52, giving investors a sense of the volatility and upside the shares have experienced over the past year. As of mid August 2026, some market references describe the stock opening at approximately $412.27 in the latest session, placing the current price level closer to the lower end of the last 12 months range than the prior high, even as the shares trade meaningfully above the 12 month low.
Recent earnings growth supports 2026 outlook
HCA Healthcare recently reported quarterly results that provide the fundamental backdrop for the current share price. In its latest reported quarter, which ended in 2026 and was released on July 24, the company generated revenue of $20.23 billion, ahead of analyst expectations of $19.76 billion for the period. That quarterly revenue figure represented year over year growth of 8.7 percent compared with the same quarter in the prior year, underlining that the companys hospital and healthcare services continue to see solid demand from patients and payors.
On the earnings side, HCA Healthcare posted earnings per share of $7.59 in that most recent quarter, slightly exceeding the consensus estimate of $7.56 by $0.03. For comparison, the company had earned $6.84 per share in the same quarter a year earlier, meaning that quarterly EPS increased by $0.75 year over year. That represents earnings growth of more than 10 percent compared with the prior years result for the same period, a performance that helps explain why the stock remains supported above the $400 mark as of August 2026.
Profitability ratios from that quarter also show a business that is generating meaningful returns from its operations. The company recorded a net margin of 8.77 percent during the quarter, reflecting the portion of revenue that translated into net profit. Analysts covering the stock currently forecast that HCA Healthcare will deliver earnings per share of 29.47 for the full current fiscal year, implying that the company needs to maintain an average quarterly EPS close to recent levels to meet those expectations.
Institutional demand and consensus view
Recent filings and portfolio disclosures suggest that institutional investors have been active in HCA Healthcare stock in mid 2026. One institutional asset manager disclosed the purchase of 379,450 HCA Healthcare shares valued at $147,944,000, signaling confidence in the companys fundamental trajectory and the broader US healthcare sector. Another institutional investor reported taking a position in HCA Healthcare valued at $116.86 million, underscoring that large professional investors continue to see the stock as an important exposure in their portfolios.
These institutional purchases are taking place against a backdrop of a supportive analyst consensus. Aggregated research coverage currently characterizes HCA Healthcare with a consensus rating described as Moderate Buy, with an average price target reported at $465.59. Relative to the roughly $412 share price level indicated for mid August 2026, that consensus price target suggests potential upside of more than $50 per share, although individual investor outcomes will depend on future market conditions, company execution, and broader healthcare policy developments.
For context, some market data summaries also note that HCA Healthcare stock has been trading up by around 1.8 percent in recent sessions when it opened at $412.27. Combined with the 12 month trading range from $353.99 to $556.52, these figures illustrate how the current price sits in the lower mid portion of that band, leaving room for both advances and setbacks depending on future earnings reports and sector news.
Hospital network and service portfolio
HCA Healthcare operates a wide network of hospitals, outpatient centers, and related healthcare facilities across the United States, with a particular concentration in fast growing regions such as the Sun Belt. The companys business model centers on providing acute care services, emergency care, surgical procedures, and a variety of specialized treatments, often in markets where population growth and demographic trends support rising demand for healthcare. HCA Healthcare also invests in technology and clinical capabilities across its facilities, seeking to improve patient outcomes and operational efficiency through standardized processes and digital tools.
Beyond core hospital services, HCA Healthcare engages in ancillary offerings such as outpatient surgery centers, diagnostic imaging, and physician practices that complement its hospital operations. By integrating these services under a single corporate umbrella, the company aims to capture a larger share of patient spending across episodes of care. The combination of acute care facilities and outpatient centers can also provide operational flexibility, allowing HCA Healthcare to adjust capacity and resource allocation as patient demand patterns evolve over time.
Stock level and investor perspective
As of the most recent indicated session in August 2026, HCA Healthcare stock has been quoted at about $412 per share on the New York Stock Exchange, with one data point showing $412.28 at 3:59 p.m. Eastern on August 18, 2026. That level sits modestly above the prior regular session close of $404.98 on August 17, 2026, reflecting a short term gain that aligns with the 1.80 percent session move identified in recent market summaries. For investors tracking price ranges, the current quote places the shares well above the 12 month low of $353.99, yet materially below the 12 month high of $556.52 noted in the same data sources.
Given this positioning, investors may focus on how HCA Healthcare executes against its revenue and earnings expectations in upcoming quarters. With the most recent quarter delivering $20.23 billion in revenue and $7.59 in EPS, and with full year EPS estimates at 29.47, the companys ability to maintain mid single digit to high single digit revenue growth and stable margins could influence whether the stock gravitates closer to the $465.59 consensus price target or remains in its current trading zone. The recent institutional buying activity and Moderate Buy consensus view suggest that a number of professional market participants currently see the risk reward balance as acceptable, but actual outcomes will hinge on future operational and macroeconomic developments.
Representative service example
One representative example of HCA Healthcares service portfolio is its network of regional hospitals that provide comprehensive emergency and acute care services to local communities. These hospitals typically offer 24 hour emergency departments, intensive care units, surgical suites, maternity services, and specialized clinics, supported by diagnostic imaging and laboratory capabilities. By integrating these services within a single facility, HCA Healthcare can coordinate patient care efficiently from admission through discharge, helping to manage length of stay and resource utilization while aiming to maintain quality outcomes.
In addition, many HCA Healthcare hospitals participate in clinical programs that address chronic conditions such as cardiovascular disease, diabetes, and respiratory illnesses, often in collaboration with affiliated physicians and outpatient centers. This integrated approach supports recurring patient relationships and can help the company sustain volume across its network, contributing to the revenue growth reflected in recent quarterly results. The ability to scale such programs across multiple markets is a key element of HCA Healthcares long term strategy.
Price snapshot and venue
HCA Healthcare stock is listed on the New York Stock Exchange under the ticker HCA. Recent market information shows the shares trading at $412.28 as of August 18, 2026 at 3:59 p.m. Eastern, with a previous close of $404.98 on August 17, 2026 in regular trading. Within the observed 12 month range of $353.99 to $556.52, this latest price level reflects a position closer to the lower portion of the bands midpoint than to the prior high, a factor that some investors may consider when evaluating valuation relative to earnings and revenue growth.
Read more
Further context on HCA Healthcare stock, including live price data and recent news, can be found on dedicated market data platforms and financial news portals that track NYSE listed companies and healthcare sector developments.
Fact box
Company: HCA Healthcare, Inc.
ISIN: US40412C1018
Ticker: HCA
Exchange: New York Stock Exchange
Price (as of August 18, 2026, 3:59 p.m. ET): $412.28 USD
12 month low: $353.99 USD
12 month high: $556.52 USD
Sector / Industry: Healthcare / Hospital operators
Index membership: S&P 500
